DE | EN | FR

Who we are and what we do

The Swiss Medical Board is a leading Swiss centre of competence in health technology assessment. It analyses and assesses preventive and diagnostic procedures and therapeutic interventions from the perspective of medicine, economic considerations, ethics and law. On this basis, it develops recommendations to political decision-makers, medical specialists and other service providers. In selected cases, information leaflets are also published for patients. 

The sponsoring membership of the Swiss Medical Board (SMB) includes the following institutions and bodies: Konferenz der kantonalen GesundheitsdirektorInnen – GDK (the Swiss conference of cantonal ministers of public health), Schweizerische Akademie der Medizinischen Wissenschaften – SAMW (Swiss academy of medical sciences), the Government of the Principality of Lichtenstein, interpharma (the association of pharmaceutical research companies of Switzerland), associations of health insurers (santésuisse, curafutura), patient organisations (Schweizerische Stiftung SPO Patientenschutz  and Dachverband Schweizerischer Patientenstellen – DVSP), and fmCh (the umbrella organisation for doctors carrying out surgery and invasive procedures).

Brief profile


Due to insufficient sunlight, there is a widespread vitamin D deficiency in Switzerland. The Federal Office for Food Safety and Veterinary Affairs...

Read more

The Executive Committee of the Swiss Medical Board (SMB) has decided to discontinue the operations of the centre of competence at the end of 2021. The...

Read more

A stay in an intensive care unit represents a severe strain for patients; often their state of health remains poor over many months. Various forms of...

Read more